02 Dec The Mysterious Way CBD Oil Can Heal Your Skin Problems
Note: Been using CBD topically and can say it totally works, not only for skin but anxiety. We use the best Endoca
“Once upon a time, people thought of their skin as a passive “wall” that should be polished so that it will glow. Instead, think of it as a complex organ that contains neuronal networks, it is constantly self-remodeling itself, and modifying non-neuronal cells and mini-organs like the hair follicle and sebaceous glands. It is also a place where immunological machinery is involved in inflammation and immune defense. and a factory of growth factors, vasoactive chemicals, and hormones.
The skin is a “feeling machine”, and it has to be because it is the means by which we interact with our environment.”
The skin is one of the many organs that is equipped with the endocannabinoid system. You may have heard about anandamine. Discovered by Rapahel Mechoulam in 1992, this is one great detective story. If humans have receptors for cannabinoids, CB1, and CB2, there has to be a natural chemical that binds to those receptors. Mechoulam and his coworkers found and characterized that natural chemical, anandamide. 2-arachidonoylglycerol is another natural ligand.
It happens that the skin also has receptors for anandamide. There is not much we can do to increase our endogenous anandamide levels, although chocolate contains chemicals resembling anandamide and I have no doubt that chocolate helps. The good news is that cannabidiol (CBD) is now allowed in skincare products and CBD could help with some skin problems. Let me tell you why.
The cannabinoid signaling extends to the skin and is involved in the maintenance of skin homeostasis, barrier formation, and regeneration. Disruption of the cutaneous cannabinoid system may be involved in several skin diseases and disorders, like atopic dermatitis, psoriasis, scleroderma, acne, hair loss, pigmentation disorders, keratin diseases, and itch. (Sivak, H. Will your skin care for cannabidiol (CBD)?.)
Cannabidiol is perhaps the most interesting compound; furthermore, it lacks the psychoactive properties of THC and is not subjected to heavy legislation. In addition, in contrast with the action of THC, it does not increase the level of β-endorphins in the plasma and in the hypothalamus.
CBD and Skin
There are plausible mechanisms for cannabidiol to have positive effects on skin.
“The cosmetic and skin care interest in CBD is justified by the fact that keratinocytes contain both types of cannabinoid receptors. This does indeed suggest that the skin might be affected when particular molecules bind to these receptors in the keratinocytes, perhaps by modulating wheal and flare in inflammatory reactions or by reducing the pain and discomfort associated with a range of skin conditions. Studies with cultured cells and animal models support this hypothesis.”
The skin has its own endocannabinoid system consisting of cannabinoid receptors which CBD can modulate. Most skin disorders result from some kind of imbalance that is manifested through inflammation. CBD can help restore that state of equilibrium through the signaling of the ECS.
The topical administration of CBD ointment, without any THC, is a safe and effective non-invasive alternative for improve the quality of life in patients with some skin disorders, especially on inflammatory background.
Can CBD Be Absorbed Through the Skin?
Dr. Awais Spall, a chemist and cannabis researcher specializing in skincare, claims that CBD is the next novel treatment for a wide range of skin conditions.
“We’ve recently discovered that the outer layer of our skin, the epidermis, has a dense network of CB1 and CB2 receptors. CBD interacts with these pathways and other nerve channels across the epidermis and dermis.”
When you use a CBD topical, the CBD interacts with the outer layer of the skin, penetrating it to reach the CB2 receptors and modulate the activity of the endocannabinoid system. This, in turn, results in antioxidant, anti-inflammatory, neuroprotective, and painkilling effects.
CBD is a more powerful antioxidant than Vitamin C, E, or A . This antioxidant property of CBD (and other cannabinoids) fights free radical damage and stimulates recovery from oxidative stress. Without antioxidants as a part of your skin care routine, oxidative stress can break down collagen, hinder skin’s natural repair process, and trigger inflammation.
Applied topically, CBD binds to a special set of receptors in the skin known as TRPV-1 receptors, where CBD can reduce feelings of pain, heat, and itch.
Inflammation impedes the skin’s natural regenerative process. By reducing inflammation and free radical damage CBD allows the skin to repair itself and correct visible signs of aging.
When your skin problem derives from inflammation or imbalances within the body, you may want to opt for products such as CBD oil, capsules, or edibles.
CBD oil has relatively high bioavailability and ensures fast effects — they usually appear within 15–30 minutes after ingestion.
- Giacomoni, P. U. CBD in Skin Care
- Stella, A., Palmieri, B., Laurino, C., & Vadalà, M. (2019). A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. La Clinica Terapeutica, 170(2), e93-e99.
- Witkamp, Renger, and Jocelijn Meijerink. “The endocannabinoid system: an emerging key player in inflammation.” Current opinion in clinical nutrition and metabolic care vol. 17,2 (2014): 130-8. doi:10.1097/MCO.0000000000000027
- Nagarkatti, Prakash et al. “Cannabinoids as novel anti-inflammatory drugs.” Future medicinal chemistry vol. 1,7 (2009): 1333-49. doi:10.4155/fmc.09.93
- Atalay, Sinemyiz et al. “Antioxidative and Anti-Inflammatory Properties of Cannabidiol.” Antioxidants (Basel, Switzerland) vol. 9,1 21. 25 Dec. 2019, doi:10.3390/antiox9010021
- Oláh, Attila et al. “Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.” The Journal of clinical investigation vol. 124,9 (2014): 3713-24. doi:10.1172/JCI64628
- Tóth, Kinga Fanni et al. “Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System.” Molecules (Basel, Switzerland) vol. 24,5 918. 6 Mar. 2019, doi:10.3390/molecules24050918
- Palmieri, B et al. “A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars.” La Clinica terapeutica vol. 170,2 (2019): e93-e99. doi:10.7417/CT.2019.2116
- Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009). The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends in Pharmacological Sciences, 30(8), 411–420. doi:10.1016/j.tips.2009.05.004
- Di Tomaso, E., Beltramo, M., & Piomelli, D. (1996). Brain cannabinoids in chocolate. Nature, 382(6593), 677–678. doi:10.1038/382677a0
- Tóth, K., Ádám, D., Bíró, T., Oláh, A., 2019. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. Molecules. doi:10.3390/molecules24050918
- Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., … Zimmer, A. (2015). Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences, 36(5), 277–296. doi:10.1016/j.tips.2015.02.008
- Slominski, AT, Michal A Zmijewski, Przemyslaw M Plonka, Jerzy P Szaflarski, Ralf Paus (2018) How UV Light Touches the Brain and Endocrine System Through Skin, and Why. Endocrinology. 2018 May; 159: 1992–2007. doi: 10.1210/en.2017-03230
- Oláh, A., Tóth, B. I., Borbíró, I., Sugawara, K., Szöllõsi, A. G., Czifra, G., . . . Bíró, T. (2014). Cannabidiol exerts sebostatic and anti-inflammatory effects on human sebocytes. The Journal of Clinical Investigation,124(9), 3713-3724. Retrieved from https://www.jci.org/articles/view/64628.
- Pucci, M., Rapino, C., Francesco, A. D., Dainese, E., D’addario, C., & Maccarrone, M. (2013). Epigenetic control of skin differentiation genes by phytocannabinoids. British Pharmacological Society. Retrieved from https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.12309.
- Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management,4(1), 245-259. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/.
- Nagarkatti, P., Pandey, R., Rieder, S., Hegde, V., & Nagarkatti, M. (2009). Cannabinoids as novel anti-inflammatory drugs. Future Med Chem,1(7), 1333-1349. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/pdf/nihms155268.pdf.
- Tóth, B. I., Dobrosi, N., Dajnoki, A., Czifra, G., Oláh, A., Szöllosi, A. G., . . . Bíró, T. (2011). Endocannabinoids Modulate Human Epidermal Keratinocyte Proliferation and Survival via the SEquential Engagement of Cannabinoid Receptor-1 and Transient Receptor Potential Vanilloid-1. Journal of Investigative Dermatology,131, 1095-1104. Retrieved from https://www.jidonline.org/article/S0022-202X(15)35276-3/fulltext.
- Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009). The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities. Trends Pharmacol Sci.,30(8), 411-420. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/.
- Dréno, B. (2017). What is new in the pathophysiology of acne, an overview. Journal of the European Academy of Dermatology and Venereology,31(S5). Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.14374.
- Expert Committee on Drug Dependence. (2017). Cannabidiol (CBD) Pre-Review Report. Expert Committee on Drug Dependence Thirty-ninth Meeting. Retrieved from https://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf.
- Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (-)delta-9-tetrahydrocannabinol are neuroprotective antioxidants. PNAS,95, 8268-8273. Retrieved from https://www.pnas.org/content/pnas/95/14/8268.full.pdf.
- Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., . . . Rahman, M. (2008). Antibacterial Cannabinoids from Cannabis Sativa: A structure-Activity Study. Journal of Natural Products,71(8), 1427-1430. Retrieved from https://pubs.acs.org/doi/10.1021/np8002673.
- Ali, E. M., Almagboul, A. Z., Khogali, S. M., & Gergeir, U. M. (2012). Antimicrobial Activity of Cannabis Sativa L. Chinese MEdicine,3. Retrieved from https://file.scirp.org/Html/10-8801078_18123.htm.
- Claims on this page have not been evaluated by the FDA and are not intended to diagnose, cure, treat, or prevent any disease.